Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

GenTegra LLC Launches New RNA Ambient Stabilization Product

Published: Friday, March 28, 2014
Last Updated: Friday, March 28, 2014
Bookmark and Share
Protect RNA samples immediately, and for all its tomorrows.

GenTegra LLC has announced the launch of GenTegra®-RNA dry Bulk.

GenTegra-RNA for the stabilization, transport and storage of purified RNA. GenTegra is a water-soluble, inert chemical matrix that inactivates trace RNase in the liquid phase, providing an added level of RNA stability during sample handling, with or without using an ice bucket.

In the dry-state, GenTegra-RNA imparts thermal stability at temperatures ranging from -80°C to 76°C and ensures quantitative recovery of RNA upon rehydration.

With the addition of GenTegra-RNA dry BULK to its line of products GenTegra LLC now offers a product that is ideally suited for automated processing of RNA samples.

Mike Hogan, GenTegra's CSO stated, "I am proud that the dry bulk form of GenTegra-RNA allows us to offer its protection to applications that were not previously feasible. Researchers now have GenTegra-RNA in a form that is ideal for stabilizing RNA samples during automated processing."

As delivered, the product has an unlimited shelf life and is ready for use by simply adding water.

Using GenTegra-RNA early in the RNA purification process provides protection at the earliest possible moment to ensure the highest possible yield of RNA.

The protection extends to virtually all forms of RNA. After sample processing the RNA solution can be dried for permanent safe ambient storage of the sample until needed.

GenTegra-RNA is ideal for protecting RNA samples that need shipping from one research lab to another. Protection from GenTegra-RNA spans the complete range of temperatures defined by both FedEx shipping and for military uses. Full protection is provided in the range of -80°C to +56°C for up to 7 months. When stored at ambient temperatures the samples are completely stable for years.

GenTegra-RNA also protects through multiple rehydration and re-drying cycles allowing up to four aliquots to be taken from the sample over time.

GenTegra-RNA dry Bulk is in stock and ready for immediate shipment.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Promise of Newborn Stem Cells to Revolutionize Clinical Practice
In this article Shweta Sharma, PhD, discusses the potential of an Umbilical Cord Blood bank as an untapped source of samples for research and clinical trials.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos